Practical Issues with Using Direct Oral Anticoagulant After Bariatric Metabolic Surgery
Author:
Publisher
Springer Science and Business Media LLC
Subject
Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Surgery
Link
https://link.springer.com/content/pdf/10.1007/s11695-023-06591-6.pdf
Reference16 articles.
1. Swartz DE, Hood L, Swartz DR, et al. 30-Day Post-Discharge Prophylaxis with Rivaroxaban Prevents Porto-Mesenteric Venous Thrombosis Following Laparoscopic Sleeve Gastrectomy. Obes Surg [Internet]. 2023 [cited 2023 Mar 12]; Available from: https://link.springer.com/10.1007/s11695-023-06471-z.
2. Kröll D, Nett PC, Borbély YM et al. The effect of bariatric surgery on the direct oral anticoagulant rivaroxaban: the extension study. Surg Obes Relat Dis. 2018;14:1890–6.
3. Martin KA, Lee CR, Farrell TM et al. Oral anticoagulant use after bariatric surgery: a literature review and clinical guidance. Am J Med. 2017;130:517–24.
4. Mueck W, Schwers S, Stampfuss J. Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring. Thrombosis J. 2013;11:10.
5. Martin KA, Beyer-Westendorf J, Davidson BL et al. Use of direct oral anticoagulants in patients with obesity for treatment and prevention of venous thromboembolism: updated communication from the ISTH SSC Subcommittee on Control of Anticoagulation. J Thromb Haemost. 2021;19:1874–82.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3